![Paul F. Howley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Paul F. Howley
Former positions of Paul F. Howley
Companies | Position | Start | End |
---|---|---|---|
PRESCIENT THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | 31/12/2007 | 31/12/2007 |
BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | 31/12/2001 | 31/12/2001 |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Corporate Officer/Principal | 04/04/2010 | - |
Training of Paul F. Howley
The University of Reading | Undergraduate Degree |
Statistics
International
Malaysia | 2 |
United Kingdom | 2 |
Denmark | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BAVARIAN NORDIC A/S | Health Technology |
PRESCIENT THERAPEUTICS LIMITED | Health Technology |
Private companies | 1 |
---|---|
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
- Stock Market
- Insiders
- Paul F. Howley
- Experience